United States scientists have succeeded in genetically editing the immune systems of three cancer patients using Crispr, without creating any side effects, a first for the tool which is revolutionizing biomedical research.
The post A new milestone for using Crispr gene-editing against cancer appeared first on Inquirer Technology.